Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fansheng Ran

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 13, 2019
Discovery of novel pyrazole derivatives as potential anticancer agents in MCLFansheng Ran, Yang Liu, Daoguang Zhang, et al.
Bioorganic Chemistry|March 3, 2020
Extensive investigation of benzylic N-containing substituents on the pyrrolopyrimidine skeleton as Akt inhibitors with potent anticancer activityYang Liu, Zhen Zhang, Fansheng Ran, et al.
Archiv Der Pharmazie|October 14, 2015
Recent Developments in Androgen Receptor AntagonistsFansheng Ran, Hualu Xing, Yang Liu, et al.
Bioorganic Chemistry|November 6, 2019
Design and synthesis of novel 1-substituted 3-(6-phenoxypyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine analogs as selective BTK inhibitors for the treatment of mantle cell lymphomaFansheng Ran, Yang Liu, Shengping Yu, et al.
Archiv Der Pharmazie|May 10, 2018
Targeting Bruton's tyrosine kinase for the treatment of B cell associated malignancies and autoimmune diseases: Preclinical and clinical developments of small molecule inhibitorsZhen Zhang, Daoguang Zhang, Yang Liu, et al.
European Journal of Medicinal Chemistry|November 29, 2021
Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinibFansheng Ran, Yun Liu, Chen Wang, et al.
Bioorganic Chemistry|April 30, 2019
Discovery of pyrazolopyrimidine derivatives as potent BTK inhibitors with effective anticancer activity in MCLFansheng Ran, Yang Liu, Meixia Liu, et al.
Bioorganic Chemistry|May 17, 2021
Design and synthesis of novel substituted benzyl pyrrolopyrimidine derivatives as selective BTK inhibitors for treating mantle cell lymphomaFansheng Ran, Yang Liu, Xin Chen, et al.
Molecular Diversity|February 18, 2026
Discovery of 5-fluoro-aminopyrimidine derivatives as dual BTK/FLT3 inhibitors for the treatment of rheumatoid arthritisFansheng Ran, Yifan Ma, Tiantian Sun, et al.
European Journal of Medicinal Chemistry|March 5, 2022
Recent development of BTK-based dual inhibitors in the treatment of cancersFansheng Ran, Yun Liu, Zhongyuan Xu, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|March 13, 2019
Discovery of novel pyrazole derivatives as potential anticancer agents in MCLFansheng Ran, Yang Liu, Daoguang Zhang, et al.
Bioorganic Chemistry|March 3, 2020
Extensive investigation of benzylic N-containing substituents on the pyrrolopyrimidine skeleton as Akt inhibitors with potent anticancer activityYang Liu, Zhen Zhang, Fansheng Ran, et al.
Archiv Der Pharmazie|October 14, 2015
Recent Developments in Androgen Receptor AntagonistsFansheng Ran, Hualu Xing, Yang Liu, et al.
Bioorganic Chemistry|November 6, 2019
Design and synthesis of novel 1-substituted 3-(6-phenoxypyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine analogs as selective BTK inhibitors for the treatment of mantle cell lymphomaFansheng Ran, Yang Liu, Shengping Yu, et al.
Archiv Der Pharmazie|May 10, 2018
Targeting Bruton's tyrosine kinase for the treatment of B cell associated malignancies and autoimmune diseases: Preclinical and clinical developments of small molecule inhibitorsZhen Zhang, Daoguang Zhang, Yang Liu, et al.
European Journal of Medicinal Chemistry|November 29, 2021
Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinibFansheng Ran, Yun Liu, Chen Wang, et al.
Bioorganic Chemistry|April 30, 2019
Discovery of pyrazolopyrimidine derivatives as potent BTK inhibitors with effective anticancer activity in MCLFansheng Ran, Yang Liu, Meixia Liu, et al.
Bioorganic Chemistry|May 17, 2021
Design and synthesis of novel substituted benzyl pyrrolopyrimidine derivatives as selective BTK inhibitors for treating mantle cell lymphomaFansheng Ran, Yang Liu, Xin Chen, et al.
Molecular Diversity|February 18, 2026
Discovery of 5-fluoro-aminopyrimidine derivatives as dual BTK/FLT3 inhibitors for the treatment of rheumatoid arthritisFansheng Ran, Yifan Ma, Tiantian Sun, et al.
European Journal of Medicinal Chemistry|March 5, 2022
Recent development of BTK-based dual inhibitors in the treatment of cancersFansheng Ran, Yun Liu, Zhongyuan Xu, et al.
Pageof 2